Capstone Therapeutics CorpOTCQB:CAPS
- LAST PRICE3.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0000/ 1
- Ask / Lots3.2000/ 1
- Open / Previous Close--- / 3.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Capstone Therapeutics Corp | 504.4K | -0.5x | --- |
Novelstem International Corp | 520.4K | -0.2x | --- |
TC Biopharm (Holdings) PLC | 332.8K | 0.0x | --- |
LadRx Corp | 365.0K | -0.1x | --- |
NovAccess Global Inc | 594.3K | -0.1x | --- |
Neximmune Inc | 338.7K | 0.0x | --- |
Company Information
Capstone Therapeutics Corp., formerly Capstone Holding Corp., operates, through its wholly owned subsidiary, TotalStone, LLC, which is a construction materials company. TotalStone, LLC distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States. The Company, through its subsidiary, Capstone Beta, LLC, owns an equity interest in Diamond Products, LLC, which is a sexual wellness products holding company. Diamond Products, LLC product portfolio includes adult toys, lingerie, games, lotions and creams that are sold globally in over 80 countries through 5,000 retailers, as well as e-commerce Websites.
Contact Information
- Headquarters
- SUITE 101, 1275 WEST WASHINGTON STREETTEMPE, AZ, United States 85281
- Phone
- 602-286-5520
- Fax
- 302-655-5049
Executives
- Chief Financial Officer, Vice President, Treasurer
- Edward Schultz
- Consultant
- Randolph Steer
- Lead Independent Director
- John Holliman
- Director
- Matthew Lipman
- Director
- Michael Toporek
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $504.4K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 157.6K |
Capstone Therapeutics Corp does not pay a dividend. | |
Beta | --- |
EPS | $-6.58 |
Book Value | $-60.70 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
